MENU
+Compare
RGNX
Stock ticker: NASDAQ
AS OF
Sep 23, 04:59 PM (EDT)
Price
$8.92
Change
-$0.14 (-1.55%)
Capitalization
457.66M

RGNX REGENXBIO Forecast, Technical & Fundamental Analysis

Regenxbio Inc is a biotechnology company... Show more

Industry: #Biotechnology
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for RGNX with price predictions
Sep 22, 2025

RGNX in downward trend: price may decline as a result of having broken its higher Bollinger Band on September 03, 2025

RGNX broke above its upper Bollinger Band on September 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 41 similar instances where the stock broke above the upper band. In of the 41 cases the stock fell afterwards. This puts the odds of success at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 17, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on RGNX as a result. In of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for RGNX turned negative on September 15, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RGNX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

RGNX moved above its 50-day moving average on August 22, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for RGNX crossed bullishly above the 50-day moving average on August 25, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where RGNX advanced for three days, in of 276 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 148 cases where RGNX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RGNX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.142) is normal, around the industry mean (19.858). P/E Ratio (0.000) is within average values for comparable stocks, (53.799). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.131). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (2.974) is also within normal values, averaging (344.050).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RGNX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

RGNX is expected to report earnings to fall 5.80% to -129 cents per share on November 05

REGENXBIO RGNX Stock Earnings Reports
Q3'25
Est.
$-1.30
Q2'25
Missed
by $0.44
Q1'25
Missed
by $0.36
Q4'24
Beat
by $0.12
Q3'24
Missed
by $0.05
The last earnings report on August 07 showed earnings per share of -137 cents, missing the estimate of -93 cents. With 185.06K shares outstanding, the current market capitalization sits at 457.66M.
A.I. Advisor
published General Information

General Information

a developer of gene therapy treatments

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
9804 Medical Center Drive
Phone
+1 240 552-8181
Employees
344
Web
https://www.regenxbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACGGX25.690.86
+3.46%
American Century Global Gold A
RPNLX14.600.09
+0.62%
RiverPark/Next Century Lg Gr Inst
COSZX14.470.07
+0.49%
Columbia Overseas Value Inst
MPLAX15.740.07
+0.45%
Praxis International Index A
IVGSX19.790.02
+0.10%
VY® Invesco Growth and Income S

RGNX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RGNX has been loosely correlated with SYRE. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if RGNX jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGNX
1D Price
Change %
RGNX100%
+1.91%
SYRE - RGNX
55%
Loosely correlated
+2.76%
DNLI - RGNX
54%
Loosely correlated
+4.47%
KYMR - RGNX
53%
Loosely correlated
+3.83%
BEAM - RGNX
52%
Loosely correlated
+0.37%
MGNX - RGNX
52%
Loosely correlated
+6.79%
More